Once-Weekly Efsitora Noninferior to Daily Insulin in T2D
CHICAGO — The investigational once-weekly basal insulin analog efsitora alfa lowered A1c as effectively as daily basal insulins in people ...
‘5 Years, 10 Years at Most, I’m Going to Retire’: What We Heard This Week
(MedPage Today) -- "A lot of my friends are in their late 50s, and they're already talking about, 'OK, maybe ...
Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes
(MedPage Today) -- CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a ...
Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of Diabetes
(MedPage Today) -- CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity ...
Can Behavioral Support Enhance CGM Use in T1D?
TOPLINE: Behavioral support for first-time users of a continuous glucose monitoring (CGM) device showed no significant difference in reduction of A1c ...
Fewer ECG Abnormalities in Early T2D With Combo Therapy
TOPLINE: In patients with type 2 diabetes (T2D) of less than 10 years' duration who were taking metformin monotherapy, ECG abnormalities ...
No budget for assisted dying service, health secretary says
EPAHealth Secretary Wes Streeting has said there is no budget for an assisted dying service, which MPs narrowly backed in ...
I Want You, Doctor, to Run for Office
(MedPage Today) -- There is an unspoken precedent within the medical community: don't do anything to alienate your patients, and ...
NFL Widows Say a New Study on CTE in Players Minimizes Their Pain
(MedPage Today) -- Dozens of widows and other caregivers for former NFL players diagnosed with chronic traumatic encephalopathy (CTE) say ...
Why quick fixes won’t lower our cortisol levels
Ruth CleggHealth and wellbeing reporterGetty ImagesIt could apparently change the shape of my face, add pounds to my midriff, and ...
Orforglipron Lowers A1c, Weight in Early Type 2 Diabetes
CHICAGO — The investigational non-peptide small-molecule oral GLP-1 agonist orforglipron significantly reduced A1c over 40 weeks in adults with early ...
Most T1D Patients Insulin-Free After Stem Cell Infusion, Small Trial Reports
(MedPage Today) -- CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...
Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes
(MedPage Today) -- CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage ...
Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss
Ecnoglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist, was significantly more effective than placebo for inducing weight loss in adults ...
Do Sugary Drinks Late in Life Raise Dementia Risk?
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/116169 ...
Population-Level Weight Loss Seen With Primary Care Protocol
CHICAGO — Encouraging patients to talk with their primary care physicians about weight management led to increased visits for obesity, ...
Stem Cell-Derived Islets Still Producing Insulin at 1 Year
CHICAGO — Ten people with type 1 diabetes, who had recurrent severe hypoglycemia and hypoglycemic unawareness, have remained insulin-independent for ...
PET Scanning for Tau in Alzheimer’s; Cannabis and Cardiovascular Risk
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for ...
Reproducibility in Medical AI: An Open, Democratic Future Is Essential
(MedPage Today) -- Artificial intelligence (AI) has made exciting strides in healthcare, with the potential to offer faster diagnoses, new ...
Abortion, DOGE, and What’s Next: Brooks-LaSure on Urgent Health Policy Shifts
(MedPage Today) -- In this installment of "Exit Interviews," MedPage Today editor-in-chief Jeremy Faust, MD, sits down with Chiquita Brooks-LaSure, ...
